Redundant signaling mechanisms contribute to the vasodilatory response of the afferent arteriole to proteinase-activated receptor-2

American Journal of Physiology - Renal Physiology

Volumn 288, Issue 1 57-1, 2005, Pages

  Wang, Xuemei ^a   Hollenberg, Morley D ^a   Loutzenhiser, Rodger ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

17 octadecynoic acid; Apamin; Charybdotoxin; Endothelium dependent hyperpolarizing factor; Nitric oxide; Ouabain sensitive Na+ K+ ATPase; Potassium channels; SLIGRL NH2; Tetrathylammonium

Indexed keywords

17 OCTADECYNOIC ACID; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANGIOTENSIN; APAMIN; BRADYKININ; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OUABAIN; PEPTIDE DERIVATIVE; PROSTAGLANDIN SYNTHASE; PROTEINASE ACTIVATED RECEPTOR 2; TETRYLAMMONIUM;

ANIMAL TISSUE; ARTERIOLE; ARTERY CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; HYDRONEPHROSIS; IN VITRO STUDY; KIDNEY PERFUSION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASODILATATION;

EID: 11144293489     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00194.2004     Document Type: Article

References (45)

1. + ATPase on EDHF relaxations in the rat hepatic artery. Br J Pharmacol 129: 1490-1496, 2000.
2. Bertog M, Letz B, Kong W, Steinhoff M, Higgins MA, Bielfeld-Ackermann A, Fromter E, Bunnett NW, and Korbmacher C. Basolateral proteinase-activated receptor (PAR-2) induces chloride secretion in M-1 mouse renal cortical collecting duct cells. J Physiol 521: 3-17, 1999.
3. Bohm SK, Kong W, Bromme D, Smeekens SP, Anderson DC, Connolly A, Kahn M, Nelken NA, Coughlin SR, Payani DG, and Bunnett NW. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J 314: 1009-1016, 1996.
4. Chilton L and Loutzenhiser R. Functional evidence of an inward rectifier potassium current in the renal afferent arteriole. Circ Res 88: 152-158, 2001.
5. Cocks TM and Moffatt JD. Protease-activated receptors: sentries for inflammation? Trends Pharmacol Sci 21: 103-108, 2000.
6. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 407: 258-264, 2000.
7. Damiano BP, D'Andrea MR, de Garavilla L, Cheung WM, and Andrade-Gordon P. Increased expression of protease activated receptor-2 (PAR-2) in balloon-injured rat carotid artery. Thromb Haemost 81: 808-814, 1999.
8. + pump activity in cultured guinea-pig tracheal smooth muscle cells. Br J Pharmacol 133: 1339-1345, 2001.
9. Doughty JM, Plane F, and Langton PD. Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium. Am J Physiol Heart Circ Physiol 276: H1107-H1112, 1999.
10. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396: 269-272, 1998.
11. Feletou M and Vanhoutte PM. Endothelium-dependent hyperpolarization of vascular smooth muscle cells. Acta Pharmacol Sin 21: 1-18, 2000.
12. Fulton D, Mahboubi K, McGiff JC, and Quilley J. Cytochrome p450-dependent effects of bradykinin in the rat heart. Br J Pharmacol 114: 99-102, 1995.
13. Gauthier KM, Deeter C, Krishna UM, Reddy YK, Bondlela M, Falck JR, and Campbell WB. 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res 90: 1028-1036, 2002.
14. +-ATPase. Pharmacol Toxicol 92: 265-271, 2003.
15. Gui Y, Loutzenhiser R, and Hollenberg M. Bidirectional regulation of renal hemodynamics by proteinase-activated receptors 1 and 2. Am J Physiol Renal Physiol 285: F95-F104, 2003.
16. Hayashi K, Loutzenhiser R, Epstein M, Suzuki H, and Saruta T. Multiple factors contribute to acetylcholine-induced vasodilation during myogenic, norepinephrine- and KCl-induced afferent arteriolar vasoconstriction: studies in the isolated perfused hydronephrotic kidney. Circ Res 75: 821-828, 1994.
17. Hiromura K, Kurosawa M, Yano S, and Naruse T. Tubulointerstitial mast cell infiltration in glomerulonephritis. Am J Kidney Dis 32: 593-599, 1998.
18. Hollenberg MD and Compton SJ. International union of pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 54: 203-217, 2002.
19. Imig JD, Falck JR, Wei S, and Capdevila JH. Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin. J Vasc Res 38: 247-255, 2001.
20. Imig JD, Navar LG, Roman RJ, Reddy KK, and Falck JR. Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol 7: 2364-2370, 1996.
21. Kawabata A, Kubo S, Nakaya Y, Ishiki T, Kuroda R, Sekiguchi F, Kawao N, and Nishikawa H. Distinct roles for protease-activated receptors 1 and 2 in vasomotor modulation in rat superior mesenteric artery. Cardiovasc Res 61: 683-692, 2004.
22. Lajoie G, Nadasdy T, Laszik Z, Blick KE, and Silva FG. Mast cells in acute cellular rejection of human renal allografts. Mod Pathol 9: 1118-1125, 1996.
23. Langton PD, Nelson MT, Huang Y, and Standen NB. Block of calcium-activated potassium channels in mammalian arterial myocytes by tetraethylammonium ions. Am J Physiol Heart Circ Physiol 260: H927-H934, 1991.
24. Lee DY, Park SK, Yorgin PD, Cohen P, Oh Y, and Rosenfeld RG. Alterations in insulin-like growth factor-binding proteins (IGFBPs) and IGBBP-3 protease activity in serum and urine from acute and chronic renal failure. J Clin Endocrinol Metab 79: 1376-1382, 1994.
25. Loutzenhiser R. In situ studies of renal arteriolar function using the in vitro perfused hydronephrotic rat kidney. Int Rev Exp Pathol 36: 145-160, 1996.
26. Loutzenhiser R, Horton C, and Epstein M. Flow-induced errors in estimating perfusion pressure of the isolated rat kidney. Kidney Int 22: 693-696, 1982.
27. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, and Plevin R. Proteinase-activated receptors. Pharmacol Rev 53: 245-282, 2001.
28. McGuire JJ, Ding H, and Triggle CR. Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor(s). Can J Physiol Pharmacol 79: 443-470, 2001.
29. McGuire JJ, Hollenberg MD, Andrade-Gordon P, and Triggle CR. Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles. Br J Pharmacol 135: 155-169, 2002.
30. McLean PG, Aston D, Sarkar D, and Ahluwalia A. Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers. Circ Res 90: 465-472, 2002.
31. Milia AF, Salis MB, Stacca T, Pinna A, Madeddu P, Trevisani M, Geppetti P, and Emanueli C. Protease-activated receptor-2 stimulates angiogenesis and accelerates hemodynamic recovery in a mouse model of hindlimb ischemia. Circ Res 91: 346-352, 2002.
32. Nakahira Y, Hashitani H, Fukuta H, Sasaki S, Kohri K, and Suzuki H. Effects of isoproterenol on spontaneous excitations in detrusor smooth muscle cells of the guinea pig. J Urol 166: 335-340, 2001.
33. Nakayama T, Hirano K, Nishimura J, Takahashi S, and Kanaide H. Mechanism of trypsin-induced endothelium-dependent vasorelaxation in the porcine coronary artery. Br J Pharmacol 134: 815-826, 2001.
34. Nilius B and Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev 81: 1415-1459, 2001.
35. Nystedt S, Emilsson K, Wahlestedt C, and Sundelin J. molecular cloning of a potential proteinase-activated receptor. Proc Natl Acad Sci USA 91: 9208-9212, 1994.
36. Ossovskaya VS and Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84: 579-621, 2004.
37. Pratt PF, Li P, Hillard CJ, Kurian J, and Campbell WB. Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs. Am J Physiol Heart Circ Physiol 280: H1113-H1121, 2001.
38. Roberts IS and Brenchley PE. Mast cells: the forgotten cells of renal fibrosis. J Clin Pathol 53: 858-862, 2000.
39. Roy SS, Saifeddine M, Loutzenhiser R, Triggle CR, and Hollenberg MD. Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: evidence for receptor heterogeneity. Br J Pharmacol 123: 1434-1440, 1998.
40. Schubert R and Nelson MT. Protein kinases: tuners of the BKCa channel in smooth muscle. Trends Pharmacol Sci 22:505-512, 2001.
41. Trottier G, Hollenberg M, Wang X, Gui Y, Loutzenhiser K, and Loutzenhiser R. PAR-2 elicits afferent arteriolar vasodilation by NO-dependent and NO-independent actions. Am J Physiol Renal Physiol 282: F891-F897, 2002.
42. Vergnolle N, Wallace JL, Bunnett NW, and Hollenberg MD. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 22: 146-152, 2001.
43. Wang X and Loutzenhiser R. Determinants of the renal microvascular response to ACh, afferent and efferent arteriolar action of EDHF. Am J Physiol Renal Physiol 282: F124-F132, 2002.
44. Wang X, Trottier G, and Loutzenhiser R. Determinants of the renal afferent arteriolar actions of bradykinin: evidence for multiple pathways mediating the vasodilator responses attributed to EDHF. Am J Physiol Renal Physiol 285: F540-F549, 2003.
45. +-channel activity. Am J Physiol Renal Fluid Electrolyte Physiol 270: F822-F832, 1996.